Drug shows promise for treating multiple food allergies

Embargoed until: Publicly released: 2024-02-26 05:45

International

CC-0. https://pixabay.com/photos/milk-splash-drops-food-liquid-4755234/

A drug called omalizumab is safe and an effective treatment for multiple food allergies, according to clinical trials of the treatment in 462 people aged between one and 55, including 180 who took part in a 'gold standard' randomised controlled trial. At the first checkpoint, 67% of the group receiving the drug saw their tolerance of allergy-inducing foods improve, compared with 7% of those given a non-active (placebo) treatment. At the second checkpoint, 41% of people given the drug saw their tolerance improve against cashew nuts, 66% against milk, and 68% against eggs, compared with 3%, 10%, and 0% respectively for the placebo group. The drug did not produce any adverse effects compared with placebo, apart from reactions at the injection site.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page The URL will go live after the embargo ends

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Johns Hopkins University School of Medicine, USA

Funder: Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT03881696

Media Contact/s

Contact details are only visible to registered journalists.